AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Cwynarski, K Goulding, R Pocock, C Dazzi, F Craddock, C Kaeda, J Olavarria, E Kanfer, E Apperley, J Lawler, M Goldman, JM
Citation: K. Cwynarski et al., Immune haemolytic anaemia following T cell-depleted allogeneic bone marrowtransplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions, BONE MAR TR, 28(6), 2001, pp. 581-586

Authors: Craddock, C Szydlo, RM Dazzi, F Olavarria, E Cwynarski, K Yong, A Brookes, P de la Fuente, J Kanfer, E Apperley, JF Goldman, JM
Citation: C. Craddock et al., Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis, BR J HAEM, 112(1), 2001, pp. 228-236

Authors: Olavarria, E Kanfer, E Szydlo, R Kaeda, J Rezvani, K Cwynarski, K Pocock, C Dazzi, F Craddock, C Apperley, JF Cross, NCP Goldman, JM
Citation: E. Olavarria et al., Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 97(6), 2001, pp. 1560-1565

Authors: Olavarria, E Hassan, M Eades, A Nilsson, C Timms, A Matthews, J Craddock, C Kanfer, E Apperley, J Goldman, J
Citation: E. Olavarria et al., A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation, LEUKEMIA, 14(11), 2000, pp. 1954-1959

Authors: Olavarria, E Parker, S Craddock, C Philpott, N Tiniakou, M Chase, A Kanfer, E Apperley, JF Goldman, JM
Citation: E. Olavarria et al., Collection of Ph-negative progenitor cells from interferon-responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization, HAEMATOLOG, 85(6), 2000, pp. 647-652

Authors: Olavarria, E Kanfer, E Szydlo, R O'Brien, S Craddock, C Apperley, J Goldman, J
Citation: E. Olavarria et al., High-dose busulphan alone as cytoreduction before allogeneic or autologousstem cell transplantation for chronic myeloid leukaemia: a single-centre experience, BR J HAEM, 108(4), 2000, pp. 769-777

Authors: Dazzi, F Szydlo, RM Cross, NCP Craddock, C Kaeda, J Kanfer, E Cwynarski, K Olavarria, E Yong, A Apperley, JF Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2612-2616

Authors: Dazzi, F Szydlo, RM Cross, NCP Craddock, C Kaeda, J Kanfer, E Cwynarski, K Olavarria, E Yong, A Apperley, JF Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2712-2716

Authors: Dazzi, F Szydlo, RM Craddock, C Cross, NCP Kaeda, J Chase, A Olavarria, E van Rhee, F Kanfer, E Apperley, JF Goldman, JM
Citation: F. Dazzi et al., Comparison of single-dose and escalating-dose regimens of donor lymphocyteinfusion for relapse after allografting for chronic myeloid leukemia, BLOOD, 95(1), 2000, pp. 67-71

Authors: Stocchi, R Szydlo, R Craddock, C Kanfer, E Apperley, JF Goldman, JM Ward, KN
Citation: R. Stocchi et al., A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantation, BONE MAR TR, 23(7), 1999, pp. 705-709
Risultati: 1-10 |